Table 4

Predictors of mortality at 1 year post-TAVI in patients with a logEuroSCORE <20%

Univariate
OR (95% CI)
P valueMultivariate
OR (95% CI)*
P value
Age (years)1.001 (0.965 to 1.038)0.9470.996 (0.950 to 1.044)0.868
Female gender1.176 (0.726 to 1.905)0.5091.482 (0.842 to 2.609)0.172
Cardiac history
 Prior MI1.028 (0.488 to 2.165)0.9420.854 (0.360 to 2.024)0.720
 Prior cardiac surgery†0.802 (0.397 to 1.620)0.5390.772 (0.337 to 1.771)0.542
 Prior stroke0.814 (0.312 to 2.123)0.6740.745 (0.248 to 2.236)0.600
Comorbidities
 AF1.716 (1.065 to 2.766)0.0271.620 (0.947 to 2.770)0.078
 Hypertension1.991 (0.601 to 6.595)0.2601.360 (0.389 to 4.761)0.630
 CAD1.815 (1.112 to 2.961)0.0172.408 (1.361 to 4.262)0.003
 Mitral valve insufficiency (>II°)1.757 (0.485 to 6.367)0.3911.636 (0.403 to 6.638)0.491
 Porcelain aorta1.263 (0.752 to 2.121)0.3771.115 (0.638 to 1.950)0.702
 Pulmonary hypertension1.628 (0.905 to 2.928)0.1041.527 (0.797 to 2.926)0.202
 COPD1.169 (0.648 to 2.110)0.6051.154 (0.605 to 2.202)0.664
 Diabetes mellitus1.166 (0.692 to 1.964)0.5640.966 (0.539 to 1.733)0.908
 Kidney insufficiency1.156 (0.721 to 1.854)0.5460.983 (0.580 to 1.667)0.949
NYHA class III or IV1.716 (0.853 to 3.453)0.1301.519 (0.732 to 3.152)0.262
LVEF (%)0.990 (0.969 to 1.011)0.3460.988 (0.964 to 1.013)0.352
Peak AV gradient (mm Hg)1.002 (0.992 to 1.012)0.7470.999 (0.978 to 1.021)0.931
Mean AV gradient (mm Hg)1.003 (0.988 to 1.018)0.6681.012 (0.981 to 1.045)0.446
  • *Adjusted for all other variables.

  • †Not including percutaneous coronary intervention.

  • AF, atrial fibrillation; COPD, chronic obstructive pulmonary disease; LVEF, left ventricular ejection fraction; MI, myocardial infarction; NYHA, New York Heart Association; STS, Society of Thoracic Surgeons; TA, transapical; TF, transfemoral.